The Secondary Data Analysis Projects are designed to bring together researchers, knowledge users and data controllers to develop research projects that answer policy and/or practice-relevant questions through the use of secondary data. The proposed research should be explicitly linked to the documented evidence needs of the knowledge user organisation.
This is a rolling call and as such there will be two separate opening and closing dates and associated peer review cycles.
2. Cycle 2
Opens for applications from 01 September 2025 at 13:00 until 09 January 2026 at 13:00
The SDAP scheme was extensively reviewed in 2024. This included analysis of grant management processes, monitoring and engagement with both the health research community and current SDAP grant holders. The following changes have been implemented to strengthen and enhance the scheme:
1. Grant Budget
The budget per grant will increase by €100,000 from €250,000 to €350,000. The enhanced budget is to assist securing appropriate, required personnel with health data expertise and/or enable training and upskilling of personnel on data management, linkage and support skills to conduct SDAP. The enhanced budget empowers capacity building across the system enhancing data expertise skillsets.
2. Project Duration
The standard SDAP duration will increase by 12 months meaning the minimum duration will be 36 months or up to 42 months if developing a tool. The increased timeline is in recognition of potential challenges regarding data curation, hiring of suitable personnel and dissemination activities to conduct the project. This should alleviate and reduce the requirement for no cost extensions.
Note: Applicants are still encouraged to consider allocating appropriate time and budget supports for Data Curation/Preparation, Data Management, Salaries and Training/Specialist skills.
3. Scope & Datasets
The SDAP scheme is designed to have direct relevance to policy and/or practice in the Irish health and social care system and is not appropriate for proposals focused solely on audits or service improvements hence these are excluded from the scope of SDAP 2025.
The datasets used must either be existing Irish or international datasets. Randomised controlled trials (RCTs) generally seek to answer one specific question under certain conditions, with limited scope outside the specific trial parameters. Data from RCTs are not appropriate when seeking to make more generalised policy and practice decisions and should ideally be avoided as dataset sources without specific justification.
4. Public/Patient Involvement (PPI)
The HRB encourages PPI to be actively considered for inclusion in all proposals where appropriate. In the event of PPI being excluded in a proposed project appropriate justification will be needed and this will be considered by the Review Panel.
How to apply
This call has two cycles each with specific opening and closing dates. Applications can be submitted to either cycle up to the relevant closing date. There are two distinct opportunities for peer review – see ‘Key dates’ section of the guidance notes. This enables researchers and knowledge users to develop collaborations and to submit their application at the time that best suits them.
All applications must be made using the HRB Grant Electronic Management System (GEMS) (https://grants.hrb.ie), and this system will close automatically at the deadline.
The application must have been reviewed and approved by the signatory approver at the research office (or equivalent) in the host institution before it is submitted to the HRB. Therefore, applicants should ensure that they give the signatory approver sufficient time before the scheme closing date to review the application and approve it on GEMS. Please note that many host institutions specify internal deadlines for this procedure.
Ensure you meet all eligibility requirements (qualifications, team makeup, research type) set out in each scheme’s guidance.
Submit through the HRB e‑management system (GEMS), approved by your institution before the call deadline.
Provide a well-conceived, hypothesis-driven proposal with solid relevance to health and social care.
Demonstrate multidisciplinarity, especially by including a dedicated statistician and, where appropriate, public health or economic expertise, which significantly boosts success odds
Having a completed pilot or feasibility study increases your chance by ~4x at shortlisting.
Include clear timelines, detailed risk management, and access to necessary infrastructure and skills (e.g. biostatisticians, data managers)
HRB requires robust PPI—your application should include users in design, implementation, and management, backed with budget and a plain-English summary, and you must reply to public reviews
HRB uses a narrative CV format based on DORA principles, rewarding diverse outputs (e.g., datasets, policy reports, public engagement) and accommodating career breaks .
Selection committees are trained to recognize unconscious bias, including gender and panel composition considerations.
Applications undergo international peer review, then panel discussion, with opportunities to revise responses .
Reviewer panel rankings may also factor in gender balance in leadership, for closely scored proposals .
HRB’s Applied Partnership Awards emphasize collaboration with end-users (e.g., HSE, patient advocates), theory-driven evidence, and real-world implementation .
📝 Summary Table
Predictor | Required Action |
---|---|
Eligibility & portal compliance | Fully meet scheme rules and submit via GEMS |
Scientific and team strength | Create a strong multidisciplinary team with a clear methodology and pilot data |
Feasibility and infrastructure | Show clear plans, timelines, risk management, and resourcing |
Meaningful PPI inclusion | Budget and plan for patient/public input and address public reviewer comments |
Use of narrative CV & DORA metrics | Emphasize diverse impact and explain career context |
Review responsiveness | Prepare to respond thoughtfully to peer and panel feedback |
End-user partnerships and impact | Involve healthcare stakeholders and plan for implementation |
💡 Pro Tips for HRB Success
Start early to secure internal approvals and institutional support in GEMS.
Include strong pilot data, even small-scale, to bolster feasibility.
Embed meaningful PPI, not just token involvement—state roles, costs, and your response to public reviews.
Use the narrative CV to highlight your full contributions and context.
Assemble the right team, including biostatisticians and domain experts.
Plan for implementation, aligning with HRB’s investment in partnerships and Irish healthcare impact.
Be ready to respond to reviews and revise applications.
Applications should be made on behalf of a team made up of researchers, knowledge users and data controllers.
In some instances, a researcher or a knowledge user may also be the data controller/processor. The applicant team should designate a Lead Applicant from the research team.
The applicant team must demonstrate clearly that the appropriate and relevant partners are involved in order to achieve the objectives set out in the research proposal and in a manner that aligns well with the sections included in the application on relevance, knowledge translation plan and impact. This round has added an additional objective: to enhance capacity for further research of this nature in Ireland through upskilling, training and education of team members where possible.
Eligible Countries:
Sponsor Institute/Organizations: Health research board
Sponsor Type: Corporate/Non-Profit
Address: Grattan House 67-72 Lower Mount Street Dublin 2 DO2 H638 Ireland +353 1 234 5000 hrb@hrb.ie
Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.
Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.
Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.
Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.
Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.
Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.
Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.
Jan 09, 2026
Jan 09, 2026
$411,154
Affiliation: Health research board
Address: Grattan House 67-72 Lower Mount Street Dublin 2 DO2 H638 Ireland +353 1 234 5000 hrb@hrb.ie
Website URL: https://www.hrb.ie/funding-scheme/secondary-data-analysis-projects-sdap-2025/
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.